Mednet Logo
CommunityDermatology

Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?

Community PollStarted

Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?

94 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet Member
Infectious Disease · Crossroads Virology
Answered on

I use mostly Linezolid because:

  • It’s now much cheaper.
  • Even if on serotonin drugs, I can half the serotonin dose while they are on it.
  • Covers pretty much all Strep and Staph, including MRSA.
  • Protein synthesis inhibition may reduce toxins (like clinda in Strep fasciitis).
  • There is no renal dose adju...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Infectious Disease · Robert Wood Johnson University Hospital
Answered on

I typically do cover both Strep and MRSA- Bactrim + 1st generation cephalosporin (e.g., Keflex or cefirdoxil) is a good combo. Single-drug options include Clindamycin and Doxycycline. Linezolid is also a good single-drug option.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Hospital Medicine · University of California San Diego
Answered on

The Infectious Diseases Society of America recommends empiric MRSA coverage for non-purulent cellulitis when specific risk factors are present, including penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, injection drug use, or systemic inflammatory response synd...

Join for free or sign in to see the full answer